Key facts
- This page summarizes Matthew Perlberg's Form 3 filing for Cigna Group (CI).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 09 Jul 2026, 19:31.
Matthew Perlberg - 01 Jul 2026 Form 3 Insider Report for Cigna Group (CI)
- Reporting owner signature
- Tyler Gratton, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Matthew Perlberg filed Form 3 for Cigna Group (CI) on 09 Jul 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002142079
Primary reporting owner
Perlberg Matthew
- Relationship
- Officer
- Address
- 900 COTTAGE GROVE RD, BLOOMFIELD
- Signature
- Tyler Gratton, attorney-in-fact
- Signature date
- 09 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CI
holding
Common Stock, $.01 Par Value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 9,345
- Date
- 01 Jul 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CI
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 791
- Exercise price
- $227.02
- Footnotes
- F1
CI
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 3,136
- Exercise price
- $294.61
- Footnotes
- F2
CI
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 5,658
- Exercise price
- $336.48
- Footnotes
- F3
CI
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 6,343
- Exercise price
- $305.86
- Footnotes
- F4
CI
holding
Derivative
Employee Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 4,643
- Exercise price
- $287.55
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
This option vested in three equal annual installments beginning March 1, 2023.
Footnote F2
This option vested in three equal annual installments beginning March 1, 2024.
Footnote F3
This option vests in three equal annual installments beginning March 1, 2025.
Footnote F4
This option vests in three equal annual installments beginning March 1, 2026.
Footnote F5
This option vests in three equal annual installments beginning March 1, 2027.
SEC remarks
Title - President, Evernorth Pharmacy & Care Delivery and EVP, Customer Innovation / EX-24 Power of Attorney